Stephen Moon’s Post

On-going supply chain disruptions, deglobalisation and a worsening economic environment are putting the spotlight on pharma logistics which needs to be more resilient, adaptable and cost effective. A strategic overhaul is needed to address these trends. With the right logistics strategy, pharmaceutical companies can successfully navigate these challenges, unlocking new efficiencies along the way. Want to find out more? Contact Lee Feander: https://lnkd.in/ePej9qtB

A&M’s EMEA teams performed Due Diligence on +900 transactions in 2023, servicing clients across multiple sectors and industries. These projects cover Financial, Commercial, Regulatory, Operational, IT and Tax Due Diligence, demonstrating the breadth and depth of A&M’s service. We provide our clients a hands-on, conflict free offering. In 2024, we continue to support our clients with action-oriented, results-driven leadership. To learn more about A&M’s offering, click here: https://okt.to/K2r4Dc #AMon #PrivateEquity #DueDiligence

With the Private Equity (PE) community being vibrant and the CFOs steering their firms through challenging times. A&M explore various operational strategies that can help PE CFOs navigate these challenges effectively. Read our latest article to find out more - https://okt.to/Q1duor #AMon #PrivateEquity #CFO

A&M appoints Managing Director Davide Arpili Alvarez & Marsal reinforces its leadership position as value creation partner for private equity firms with the appointment of Davide Arpili Based in A&M’s growing Barcelona office, Davide brings over 25 years of experience in more than 100 large-scale change transformation programmes, transactions and post-merger integrations. He will support private equity firms and their portfolio companies with cross-border growth, performance improvement and integration programs To learn more about Davide, please explore his profile: https://okt.to/U0t8lo #Amon #PEPI

Penlon's Director of Innovation, Technology and Regulatory Affairs, Mary Ryan, was recently shortlisted for two awards in this year's Thames Valley Business and Community Awards. The winners were announced at a ceremony on Thursday, 25th January. Of the 1100 nominees, Mary was chosen as a top three finalist in two categories, 'Innovator of the Year' and 'Lifetime of Achievement' Awards. Although Mary did not win those categories, the celebrations took an unexpected turn during the evening when she received the 'Special Recognition Award' for the body of work she has delivered over the years in the Health and Medtech Industries with a focus on the NHS Ventilator Challenge.  Mary said: "I was so proud to receive this accolade. I was beaming and sharing the story about all the work that we have done and achieved at Penlon." Mary was joined for the evening by her colleague Dan Harrison, QARA Manager. The evening was well attended, with the room full of fantastic businesses, worthy shortlisted nominees and winners, with a special keynote speaker, Fatima Whitbread MBE. Mary added, 'It was a privilege to meet and speak to Fatima Whitbread, particularly as she was one of my childhood sporting heroes and a huge inspiration to me'. Congratulations, Mary, on this unique and well-deserved award. #healthcare #medicaldevices #partnership #innovation #TVBCAWARDS

With the launch of ChatGPT, businesses including #PrivateEquity are exploring how to leverage the technology as well as the threats and opportunities it offers. Managing Director chris gobby contributes his thoughts on what Generative AI means for #PE in Private Funds CFO. https://okt.to/PuSTWr #AMon #GenerativeAI

73% of investors in carve-outs use the sign-to-close period to accelerate value creation realisation. In our view, organisational stand-up presents a critical lever for accelerating value creation through the early delivery of an optimised end-state operating model that can also minimise one-off costs. Underpinning our approach to carve-outs are several key benefits that we can realise through the stand-up of organisations, read our latest article to find out more. https://okt.to/ktuc2s Dominic Orchard Philip Allan Dr. Tim Veen #Amon #CarveOuts #PrivateEquity

A&M has enhanced its Commercial Due Diligence (CDD) capability with several new appointments to its Private Equity Performance Improvement practice. With 15 new senior CDD hires across Europe, the moves form part of the firm’s strategy to create integrated commercial, financial, tax and operational due diligence in a comprehensive pre-deal offering that will provide a genuine transformation post-deal roadmap.   Read the release here: https://lnkd.in/ep3Zy9YR #AMon #CommercialDueDiligence #PrivateEquity #CDD #Transformation Torbjörn Månsson, Johan Lundgren, Oleg Zubarev Nick Mountfield Rodrigo Rodríguez Gallego, Harald Meinders, Mike Trenouth

Why did Associate André G. decide to start his career at A&M? He was led by the opportunity to work with seasoned industry professionals and learn from their deep operating expertise. Due to A&M’s flat structure, there is opportunity for direct interaction with leadership even at a junior level. Want to follow in Andre’s footsteps? Listen here to what Andre shares about relationship building and the importance of adaptability at A&M. https://okt.to/qlNwt5 #AMon #CompanyCulture #Careers #AMteamEMEA